N-substituted saturated heterocyclic sulfone compounds with CB2 receptor agonistic activity
US8653063B2 · kind B2 · utility
1Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 22, 2010 |
| Grant date | Feb 18, 2014 |
| Priority date | — |
| Expiry date | Dec 10, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R1, R2, R3, R4, R5, R6, R7, k, m, n, p, q, r and s are each as described herein, and compositions containing such compounds, and the use of such compounds in the treatment of a condition mediated by CB2 receptor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.